Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mereo BioPharma (MREO) Gross Profit (2023 - 2025)

Mereo BioPharma (MREO) has disclosed Gross Profit for 2 consecutive years, with $400000.0 as the latest value for Q2 2025.

  • On a quarterly basis, Gross Profit changed N/A to $400000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $400000.0, a 73.49% decrease, with the full-year FY2023 number at $7.4 million, up 747.99% from a year prior.
  • Gross Profit was $400000.0 for Q2 2025 at Mereo BioPharma, down from $1.3 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $6.3 million in Q2 2023 to a low of -$347000.0 in Q1 2023.